Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Modern Age vs OurView Health

Modern Age
Graded #362

Lower grade

vs+8.899999999999991
OurView Health
Graded #162

Higher grade

The verdict

OurView Health takes it — 67.6/100 to 58.7/100.

OurView Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOurView Health +31
45
76
Dose & formulationOurView Health +11
53
64
Clinical oversightModern Age +4
83
79
Labs & monitoringModern Age +24
77
53
FulfillmentOurView Health +11
59
70
Contract termsOurView Health +25
20
45
Modern Age · left barOurView Health · right bar

The numbers

MetricModern AgeOurView Health
WeighScore58.7/10067.6/100
GradeCC
Scorecard rank#362#162
SemaglutideNot disclosed$75/mo (starting dose, compounded)
TirzepatideNot disclosed$135/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Modern Age

Graded #362 · C

Strengths

  • Uses FDA-approved branded GLP-1 medication (Wegovy/Ozempic), no compounding
  • Comprehensive assessment with labs, at-home tests and clinician review
  • Board-certified clinicians and structured 6-month program
  • Longevity-oriented, whole-person approach beyond weight loss

Where it loses points

  • Expensive: $500 assessment plus $500 program, with medication billed separately
  • Branded GLP-1 can cost $900-1600/mo if not covered by insurance
  • Only available in 16 states (specific states not listed publicly)
  • Premium positioning makes it costlier than compounded-subscription rivals
OurView Health

Graded #162 · C

Strengths

  • Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
  • Clear product pricing with no contracts; medication shipped to your door (30-day supply)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
  • Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)

Where it loses points

  • A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
  • Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard